ArticleBJS open2026
Pattern of lymph node spread in gastric cancer: Western multicenter retrospective study.
Article in BJS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer is a biologically heterogeneous disease with variable patterns of lymph node (LN) metastasis influenced by tumour biology and anatomical location. Contemporary Western data on LN dissemination remain limited.
methodsThis retrospective multicentre study evaluated data from patients with resectable gastric adenocarcinoma who underwent curative-intent gastrectomy at five high-volume European centres. LN retrieval and metastatic involvement were analysed according to tumour location, Lauren histotype, pathological (p) stage, neoadjuvant chemotherapy, and microsatellite status (microsatellite instability (MSI) or microsatellite stable (MSS)). Lymph node stations were analysed individually and grouped into three anatomical tiers based on proximity to the stomach, according to the Japanese Gastric Cancer Association classification.
resultsIn all, 950 patients were included in the study. The incidence of LN metastasis in diffuse and mixed histotypes was approximately twice that of intestinal-type tumours, along with higher metastatic rates across multiple perigastric first-tier and selected second-tier stations (P < 0.050 to P < 0.001). The anatomical pattern of lymphatic spread was site-specific, with consistent drainage pathways across tumour locations. In early gastric cancer, LN metastases were rare and largely confined to stations 3 and 4. Neoadjuvant chemotherapy reduced overall nodal burden without altering the anatomical distribution of metastatic stations. MSI tumours exhibited lower nodal involvement than MSS tumours, with higher rates of node-negative disease (49.3% versus 41.3%) and fewer patients with pN3 tumours (15.9% versus 27.7%; P = 0.044).
conclusionsTumour location influenced the anatomical pattern of LN spread, whereas histological and molecular features were associated with differences in metastatic risk and extent. The integration of biological and anatomical factors may support more tailored surgical strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.